Australia's most trusted
source of pharma news
Friday, 10 April 2026
Friday, 10 April 2026
Subscribe
Login
Novartis leader nabs GM role
This well-known industry executive has clearly impressed, earning a promotion to a Country Leadership role after leading the ANZ team on an interim basis.
Double-whammy Code breach fine
ICYMI: Two companies slapped with fines for breaching the Aussie Code of Conduct plus the other most popular stories this week
TODAY Your Week in 5 Minutes
Who's joined the TGA's review list?
Five drug applications were accepted for review in February, including new indications for two big products
TODAY
$210K tit-for-tat Aussie Code fines
Two companies have been fined in a double whammy claim and counterclaim for breaching the MA Code of Conduct
9 April
Meet industry's $50M-a-year Boss
This CEO has notched some impressive milestones for his company and he's been handsomely rewarded for his efforts
9 April
Marketers 'not quite up to notch'
Survey finds 65 per cent of HCPs have reduced or stopped engagement with a pharma due to poor digital experiences
9 April
Local exec scores GM ANZ role
Second-ever General Manager for Australia and New Zealand appointed after the founding GM, Michael Azrak, jumped to Novo Nordisk
8 April
Latest Jobs
Senior Territory ManagerData & Insights AnalystInventory AnalystCustomer Service RepresentativeClinical Trials InvestigatorCustomer Service SpecialistCustomer Service RepresentativeCustomer Service Lead22 more...
Pharma in Focus Jobs
Marketing & Communications (3)
- Data & Insights Analyst - Melbourne
- Senior Medical Communications Specialist - Sydney
- Brand Manager - Macquarie Park
Sales & Customer Relations (14)
- Senior Territory Manager - Melbourne
- Customer Service Representative - East Ryde
- Customer Service Specialist - Frenchs Forest
- Customer Service Representative - St Leonards
- Customer Service Lead - Frenchs Forest
- Hospital Specialist Representative - Melbourne
- Commercial Analytics & SFE Specialist - Sydney
- Pharmaceutical Sales Representative - Sunshine Coast
- Customer Service Representative - Canning Vale
- Account Manager - Melbourne
- Accountant - Macquarie Park
- Customer Service Representative - Belrose
- Customer Service Representative - St Leonards
- Account Manager - Sydney
Clinical & Medical, R&D (6)
- Clinical Trials Investigator - Melbourne
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Medical Lead - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
- Senior Medical Communications Specialist - Sydney
- Warehouse & Medical Kit Assistant - Blacktown
Regulatory, Pharmacovigilance & QA (2)
- Pharmacovigilance and Medical Information Associate - Sydney
- Regulatory Affairs Specialist - Lane Cove
Executive Roles (1)
Other (8)
New battle in obesity kicks off
FDA approves Lilly's obesity pill putting it in a head-to-head battle with Novo Nordisk... and the drug's new trade name is finally out
TODAY
Pharmac funds time-saving meds
Newly announced funding for cancer drugs, and an antiviral, are expected to reduce the time patients need to be in hospital
TODAY
Pharmacy chain dominates market
New rankings across the Australian pharmacy chain market have been released revealing who's on top... including a surprise achiever
9 April
Multiple roadblocks for IBD drugs
Despite a high disease burden and high cost to the health system, new drugs to treat IBD aren't landing in Australia, according to patients
9 April
Trump tariffs unleash hidden chaos
The US President threw a fox into the Easter Bunny hutch over the Easter Long Weekend and Big Pharma could pay the price
8 April
What Chat says about your drugs
AI answer engines are delivering medical info about particular products that are alarming and companies are in the dark
8 April
Lift-off for Australian-made drug
Prescription medicine developed and manufactured in Australia officially launched as the only TGA-registered treatment of its kind
8 April
SOS distress call for PBS listing
Only three months remaining until the PBAC considers this pharma's revised proposal for an expanded PBS listing for younger children
8 April
Four brands hit with price cuts
April has brought first new brand competition for four drugs, each hit with a 25 per cent statutory reduction in price
7 April
After 1192 days, is funding in sight?
It's been over four years since the HTA process for this next-gen cancer treatment began but the wait may soon be over
7 April
And again... MA fills media role
Seasoned public affairs leader named as the industry body's new Senior Media Advisor, its sixth in as many years
7 April
Event draws global thought leaders
Hundreds of prostate cancer experts from around the world descended on Melbourne to unpack advances in care
7 April
First oral SERD registered
Finally registered on the ARTG, marking the first oral SERD in Australia with the company actively seeking reimbursement
7 April Approvals Action
Who's on a major hiring spree?
This company has launched a massive recruitment drive, hunting for the best talent as it grows its business for the next chapter
2 April